Immunohistochemical Analysis of Cyclin D1 Protein in Hematopoietic Neoplasms with Special Reference to Mantle Cell Lymphoma-Reference-Cited by-同舟云学术

Immunohistochemical Analysis of Cyclin D1 Protein in Hematopoietic Neoplasms with Special Reference to Mantle Cell Lymphoma

Published:1994-12 Issue:12 Volume:85 Page:1270-1279
ISSN:0910-5050
Container-title:Japanese Journal of Cancer Research
language:en
Short-container-title:

Author:

Nakamura Shigeo,Seto Masao,Banno Shogo,Suzuki Susumu,Koshikawa Takashi,Kitoh Kuniyoshi,Kagami Yoshitoyo,Ogura Michinori,Yatabe Yasushi,Kojima Masaru,Motoori Tadashi,Takahashi Toshitada,Ueda Ryuzo,Suchi Taizan

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.1994.tb02940.x/fullpdf

Reference33 articles.

1. Mantle cell lymphoma: a proposal for unification of morphologic, immunologic, and molecular data;Banks;Am. J. Surg. Pathol,1992

2. An overview of the classification of non-Hod gkin's lymphomas: an integration of morphological and phenotypical concepts;Jaffe;Cancer Res.,1992

3. Lymphomas of follicles. Mantle cell and follicular center cell lymphomas;Weisenburger;Am. J. Clin. Pathol,1993

4. Lymphocytic lymphoma of intermediate differentiation- mantle zone lymphoma. A distinct subtype of B-cell lymphoma;Jaffe;Hum. Pathol.,1987

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunohistochemical evaluation of cyclin D1 and p63 in odontogenic keratocyst and unicystic ameloblastoma;Revista Española de Patología;2024-07

2. Immunohistological recognition of cyclin D1 expression by non-lymphoid cells among lymphoid neoplastic cells;APMIS;2013-06-12

3. The Critical Role of Histology in an Era of Genomics and Proteomics: A Commentary and Reflection;Advances in Anatomic Pathology;2007-11

4. Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas: Results of a Japanese Phase II Study;International Journal of Hematology;2004-10-01

5. Japanese multicenter phase II and pharmacokinetic study of rituximab in relapsed or refractory patients with aggressive B-cell lymphoma;Annals of Oncology;2004-05